Delivered by Eng. Nizar Al-Hariri, President, National Industrial Development Center, Saudi Arabia at the Global Forum 2020 Innovators from the Field session.

1. GLOBAL FORUM2020
3 R D
S A V I N G L I V E S S U S T A I N A B L Y:
SUSTAINABLE PRODUCTION IN THE HEALTH SECTOR
GLOBAL FORUM | 2020 RIYADH
Innovators from The Field
By: Eng. Nizar Al-Hariri,
CEO, National Industrial
Development Center

2. THE COVID-19 PRIORITY SECTORS
GLOBAL FORUM 2020

3. MEDICAL DEVICES

4. SAUDI MEDICAL DEVICES MARKET
GLOBAL FORUM 2020
Of market size represents
Governmental purchase70%
Cumulative annual growth rate
5%
Market Size
usd4.8bn
Factories, most of them
produce disposables and PPEs50
Importation of medical devices
94%
Employees in 50 factories.
3K

5. N95 (K per day)
Stimulus Impact
Within a period of 4 months, the stimulus resulted in dramatic boost in production:
GLOBAL FORUM 2020
60
135
0
50
100
150
Before After
Mn
50
150
0
50
100
150
200
Before After
K
Gloves (Mn per annum) Gowns (K per day)
Mn
0.45
4.7
0
2
4
6
Before After
Masks (Mn per day)
K
0.06
150
0
50
100
150
200
Before After
Creation of new industeries:
Ethynyl Alcohol
▪ Localization of Ethyl
alcohol.
Ventilator
▪ Full design and
manufacturing of an ICU
ventilator.
▪ (under certification process)
Hand Sanitizer
▪ 70+ manufactures
▪ 4.6 Mn/liter per
week.

6. Industry 4.0
GLOBAL FORUM 2020
The governmental launch industry 4.0 initiative to assist factory transformation, through:
Big data, Internet of the things, smart sensors, cloud computing, etc. would provide
Optimal resources
utilization
Reduced CO2
emissions
Automation to
replace low-
skilled labors
Provision of high-
skilled labors
Funding
SIDF provides loans up to 75%
via IDT Program (Industrial
Digitization Transform.)
Free Readiness Assessment
MODON provides a free
readiness study for tenants

7. PHARMACUITICALS

8. GLOBAL FORUM 2020
KSA is the largest pharma market in the MENA region and
sits at the heart of the large regional and global market
1.2
Global
$T
MENA
$B
KSA $B
33% of MENA
0.7% of Global
Global $ 1.2TSmall Molecule
Market
Large Molecule
Market
Vaccines: $0.5B
Plasma: $0.1B
Biologics/Biosimilars:
$1.8B
Oral Solids: $3.5B
APIs :$0.2B
Sterile Injectables:
$0.7B
1.2
$777B $444B
MENA $ 25.3B
KSA $8.6B
8.625.3

9. 1st Priority List 2nd Priority List
Available in 3 or more of Exposure
Lists
Identify APIs market sizes (local,
MENA, global).
Identify small & large molecules
(Done)
Identify APIs global Producers
Analyze and link their value chains.
Evaluate local manufacturing and
export capabilities.
Available in 2 Exposure Lists
Industrial Analysis is On-going
Done
GLOBAL FORUM 2020

10. 10
KSA Path Forward
Build (or acquire)
capabilities across the
value chain and into new
technology platforms
Focus on chemical to
pharma and to,
- Close the gaps in the
manufacturing value
chain
- Capitalize on massive
experience of KSA in
petrochemicals> move to
specialties.
Short term
Med-Long term
Realization
Continue to
attract and
develop
investments
along the
pharma value
chain
GLOBAL FORUM 2020

11. GLOBAL FORUM2020
THANK YOU